4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000003
Chief Executive Officer sold 18,333 shares at $9.06 ($166,082)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Congleton Jon Chief Executive Officer | 2025-01-13 | Sale 10b5-1 | −18,333 | $9.06 | $166,082 | 877,608 | D |
| Open-market sales · 18,333 sh · avg $9.06 · $166,082 | |||||||
Loading xslF345X05/wk-form4_1736995487.xml…